Rutgers Cancer Institute of New Jersey /ID# 274358 — New Brunswick, New Jersey

Rutgers Cancer Institute of New Jersey /ID# 274358 is a clinical research site located in New Brunswick, New Jersey, United States 08901.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Rutgers Cancer Institute of New Jersey /ID# 274358 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer.

Sponsors: AbbVie.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in New Brunswick

Browse all research sites in New Jersey · View every site in New Brunswick

• Rutgers, The State University of New Jersy
• Rutgers University Department of Neurosurgery
• UMDNJ-RWJ University Orthopedic Group
• Robert Wood Johnson Hospital
• University Medicine and Dentistry of New Jersey
• University Behavioral HealthCare (UBHC) Extended Treatment
• Robert Wood Johnson Univeristy Hospital
• Rutgers, The State University
• Rutgers University, Department of Food Science
• University of Medicine and Dentistry of NJ
• RWJ University Hospital - N Brunswick
• University of Medicine & Dentistry of New Jersey, UMDNJ Scleroderma Program

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rutgers Cancer Institute of New Jersey /ID# 274358?

Rutgers Cancer Institute of New Jersey /ID# 274358 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rutgers Cancer Institute of New Jersey /ID# 274358 conducted?

Rutgers Cancer Institute of New Jersey /ID# 274358 has 1 clinical trials on record, with 1 currently active. Their work covers Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer.

Is Rutgers Cancer Institute of New Jersey /ID# 274358 accredited by Crixeo Clinical Trials?

Rutgers Cancer Institute of New Jersey /ID# 274358 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rutgers Cancer Institute of New Jersey /ID# 274358?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.